FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season

FDA Approves First-Ever RSV Vaccine After Brutal 2022 Season

Upworthy

Published

The Food and Drug Administration approved a first-of-its-kind RSV vaccine by pharmaceutical company GlaxoSmithKline for older adults on Wednesday, in time to help the U.S. combat RSV infections and deaths this year after a severe 2022 season. GlaxoSmithKline’s Arexvy is now approved for people…

#rsv #arexvy #fda #glaxosmithkline #abc #cdc #gsk #moderna #todaymarks #tonywood

Full Article